Jones Financial Companies’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
10,449
-1,087
| -9% | -$18.2K | ﹤0.01% | 1711 |
|
|
2025
Q1 | $174K | Buy |
11,536
+2,944
| +34% | +$44.4K | ﹤0.01% | 1545 |
|
|
2024
Q4 | $189K | Buy |
8,592
+5,091
| +145% | +$112K | ﹤0.01% | 1380 |
|
|
2024
Q3 | $61.1K | Buy |
3,501
+3,394
| +3,172% | +$59.3K | ﹤0.01% | 1572 |
|
|
2024
Q2 | $1.73K | Buy |
+107
| New | +$1.73K | ﹤0.01% | 2190 |
|
|
2023
Q2 | – | Sell |
-200
| Closed | -$1.77K | – | 593 |
|
|
2023
Q1 | $1.77K | Buy |
+200
| New | +$1.77K | ﹤0.01% | 556 |
|
|
2016
Q4 | – | Sell |
-8,051
| Closed | -$370K | – | 232 |
|
|
2016
Q3 | $370K | Sell |
8,051
-499
| -6% | -$22.9K | ﹤0.01% | 186 |
|
|
2016
Q2 | $429K | Sell |
8,550
-1,101
| -11% | -$55.2K | ﹤0.01% | 182 |
|
|
2016
Q1 | $517K | Sell |
9,651
-1,832
| -16% | -$98.1K | ﹤0.01% | 169 |
|
|
2015
Q4 | $754K | Sell |
11,483
-1,769
| -13% | -$116K | ﹤0.01% | 164 |
|
|
2015
Q3 | $748K | Sell |
13,252
-1,564
| -11% | -$88.3K | ﹤0.01% | 166 |
|
|
2015
Q2 | $875K | Sell |
14,816
-1,845
| -11% | -$109K | 0.01% | 156 |
|
|
2015
Q1 | $1.04M | Sell |
16,661
-909
| -5% | -$56.6K | 0.01% | 152 |
|
|
2014
Q4 | $1.01M | Buy |
17,570
+560
| +3% | +$32.2K | 0.01% | 160 |
|
|
2014
Q3 | $915K | Sell |
17,010
-136
| -0.8% | -$7.32K | 0.01% | 163 |
|
|
2014
Q2 | $899K | Sell |
17,146
-65
| -0.4% | -$3.41K | 0.01% | 159 |
|
|
2014
Q1 | $910K | Sell |
17,211
-8,565
| -33% | -$453K | 0.01% | 158 |
|
|
2013
Q4 | $1.03M | Sell |
25,776
-1,993
| -7% | -$79.9K | 0.01% | 156 |
|
|
2013
Q3 | $1.05M | Buy |
27,769
+994
| +4% | +$37.5K | 0.01% | 147 |
|
|
2013
Q2 | $1.05M | Buy |
+26,775
| New | +$1.05M | 0.01% | 141 |
|